The Growth Guarantee Scheme is a clean measurement of how UK small-business lending has shifted onto fintech rails. The British Business Bank’s £2.5 billion GGS milestone announced on 27 July 2025 was distributed through 50-plus delivery partners across 53 accredited lenders — a roster of challenger banks, specialist asset-finance fintechs and platform aggregators alongside the traditional clearers. The Bank’s own Small Business Finance Markets 2024/25 report records challenger banks at 60% of all UK bank lending in 2024 — the highest share ever recorded.
That distribution map matters for two reasons. Scottish fintechs operate in the same SME lending stack the GGS runs through. And GGS is structurally the wrong instrument for most of Scotland’s tech and life sciences pipeline — but the right one for a specific slice of it: hardware-heavy companies that may need equipment finance to scale.
How GGS is distributed
GGS is a UK government 70% guarantee on lender losses; the lending itself sits on commercial balance sheets. Of the 53 accredited lenders, a substantial share are challenger banks and specialist platform lenders rather than high-street incumbents — Allica Bank, Funding Circle, OakNorth, ThinCats, iwoca, Simply Asset Finance and Paragon Bank are all accredited. Aggregator platforms such as Swoop Funding sit on top, routing applications through multiple accredited lenders in parallel.
The breakdown by facility type signals where fintech distribution is concentrated. At the £2.5 billion milestone, £1.73 billion (73%) had been drawn as business term loans, £553 million (24%) as asset finance, £64 million (3%) as invoice finance and £7 million as revolving credit. Asset finance is where specialist fintech lenders dominate — competing on underwriting speed and asset-class expertise, both technology problems. Term lending is more contested, with challenger banks taking share from incumbents in the £150,000 to £2 million band. Invoice finance and asset-based lending sit under 5% of drawdowns despite a £1,000 minimum — a category where Scottish fintech entrants could compete credibly.
Why GGS is the wrong product for most Scottish tech
The structural mismatch with most of Scotland’s tech and life sciences sector is worth stating clearly. GGS is debt — repayable with interest, on a fixed term of up to six years, against a viability test the lender has to sign off. Most growth-stage technology businesses cannot use it for three reasons.
First, most Scottish tech companies need equity, not debt. Pre-revenue software, deep tech, AI, fintech platform and most life sciences businesses raise equity because their cash flows do not support debt service in the early years. Layering a £500,000 GGS term loan onto a pre-revenue Series A company compounds risk rather than reducing it.
Second, the viability test excludes most pre-revenue companies. The scheme requires lenders to consider the borrower has “a viable business proposition” — language that in commercial credit underwriting typically requires trading history, predictable revenue and demonstrable debt-service capacity. A spin-out 18 months from clinic, a quantum hardware company two years from first commercial order, or a fintech 12 months from its FCA permissions decision will struggle to clear that bar.
Third, subsidy limits constrain stacking. GGS counts as a subsidy under UK rules and there are cumulative limits over rolling three-year periods. Companies already receiving Innovate UK grants, Scottish Enterprise loans, R&D tax credits or Scottish National Investment Bank facilities may find their GGS headroom reduced or eliminated.
For a substantial portion of Scotland’s tech pipeline — software, deep tech, life sciences pre-revenue companies, most fintechs in their authorisation phase — the Growth Guarantee Scheme is not a route to growth capital. Equity, grants and the Scottish National Investment Bank’s revenue-based products remain the appropriate instruments.
Where GGS does fit — hardware-heavy Scottish tech
The exception is hardware. Scotland’s Critical Technologies Supercluster — quantum, photonics, semiconductors, advanced sensing — comprised more than 150 companies and generated £4.2 billion in turnover in 2022, with a stated trajectory to £10 billion and 17,500 jobs by 2035, according to Scotland’s Technology Council 2025–26 report. That is the segment where GGS becomes useful, and where asset finance — 24% of GGS drawdowns nationally — is most relevant.
Quantum hardware needs clean-room fabrication and cryogenic systems; photonics manufacturers need laser systems and automated test rigs; robotics companies need machine tools and integration cells. In each case the asset is identifiable, has secondary-market value and can be financed against itself — which is what asset finance is structurally built to do.
The companies that fit this pattern are real and growing. Glasgow-based Quantcore raised £2.5 million in seed funding in February 2026 to build the UK’s sovereign supply chain for niobium-based quantum components — the kind of business that may need asset finance for fabrication equipment as it scales from prototyping to first commercial production. Edinburgh’s Skylark Lasers, M-Squared Lasers and Kelvin Nanotechnology sit in similar positions, and the wider robotics sector around Heriot-Watt’s National Robotarium faces the same equipment-finance challenges.
That alignment is what makes the £1,000 minimum on GGS asset finance facilities, the £2 million ceiling, the six-year term and the 70% government guarantee materially useful to a specific Scottish tech segment. The scheme does very little for software; it can do something useful for hardware companies past first revenue and equipment-constrained on the next step.
What to take from this
For Scottish hardware tech operators, GGS is worth taking seriously as a route to equipment finance, particularly through the specialist asset-finance lenders on the accredited list. The £1,000 minimum makes it accessible to early-stage hardware companies, and the £2 million ceiling supports meaningful production scale-up. For everyone else — pre-revenue software, deep tech and most life sciences — equity, grants and the Scottish National Investment Bank remain the right instruments.
The question for any Scottish technology board is not whether GGS exists, but whether the company’s capital structure, stage and asset base actually fit the product. For a clear minority of Scotland’s tech sector, it does. For the majority, it does not.
This piece extends our High Growth Scotland coverage of Scotland’s £127m drawdown across 766 GGS facilities and the UK demand-side picture — read that for the underlying scheme mechanics, regional spread and Scottish lending data.
